Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Also Known As
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Similar Companies1000
Congenica
Congenica provides a diagnostic decision support platform for genetic diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
Cypher Genomics
Cypher Genomics provides automated genome interpretation for diagnostics development and biomarkers.
Sector
Subsector
Location
total rounds
Convergent Genomics
Convergent Genomics is a precision medicine company that uses genomics and machine learning to detect cancer early and non-invasively.
Sector
Subsector
Keywords
Location
NextCODE Health
NextCODE is a genomic information company that uses sequence data to improve health globally.
Sector
Subsector
Location
total rounds
total raised
Financials
Funding Rounds9
Number of Funding Rounds
Money Raised
Their latest funding was raised on 16.05.2024. Their latest round Venture - Series Unknown
Beringea
Beringea is a venture capital firm supporting entrepreneurs to build successful businesses.
Sector
Subsector
count Of Investments
count Of Exists
National Institutes of Health
NIH conducts research to improve health and reduce illness and disability.
Sector
Subsector
Keywords
Location
total rounds
total raised
count Of Investments
count Of Exists
Co-Investors
Investors20
Number of lead investors
Number of investors
National Institutes of Health
NIH conducts research to improve health and reduce illness and disability.
Sector
Subsector
Keywords
Location
total rounds
total raised
count Of Investments
count Of Exists
Beringea
Beringea is a venture capital firm supporting entrepreneurs to build successful businesses.
Sector
Subsector
count Of Investments
count Of Exists
Michael Gross
Michael is responsible for investment sourcing, deal execution and portfolio management, with a focus on healthcare, technology enabled services, and sustainability. Michael serves as a board director for Beringea portfolio companies Molecular Imaging, Delphinus Medical Technologies, InTouch Health, Intervention Insights, Xanitos, Freeosk, and Fiber By-Products, and is a board observer for MedVantx. Previous portfolio companies include Pioneer Surgical Technology (acquired by RTI Biologics), Relume Technology (acquired by Revolution Lighting), and Ecosynthetix (TSX: ECO). Prior to joining Beringea, Michael was a vice president of investment banking with P&M Corporate Finance (PMCF). While at PMCF, Michael led M&A transactions and capital raises for companies in the life sciences, health care and outsourced business services sectors. Before working at PMCF, Michael worked in the investment banking group at Stout Risius Ross, Inc. Michael is a CFA charterholder and earned a B.A. in Finance from Michigan State University.
current job
BroadOak Capital Partners
BroadOak Capital Partners is a privately held investment bank that focuses on the life sciences industry.
Sector
Subsector
Location
count Of Investments
count Of Exists
People
Founders3
Megan S. Lim
Megan is the Director of the Hematopathology and Professor of Pathology and Laboratory Medicine at the Hospital of the University of Pennsylvania.
current job
organization founded
Megan S. Lim
Mark J. Kiel
Mark J. Kiel is Founder and Chief Science Officer at Genomenon where he oversees the company’s scientific direction and product development. Prior to starting Genomenon, Mark completed his residency in Clinical Pathology in 2014 at the University of Michigan. While at Michigan, he completed a fellowship in Molecular Diagnostics and devised the informatics framework for clinical next-generation sequencing in the Molecular Diagnostics Laboratory. While a post-doctoral researcher under Drs. Kojo Elenitoba-Johnson and Megan Lim, he made significant contributions to the field of Hematopathology including genomic profiling of lymphoid malignancies for which he was awarded the Benjamin Castleman Award. During his doctoral studies with Sean Morrison, he made seminal contributions to the study of hematopoietic stem cells for which he was awarded the Weintraub International Graduate Student Award and the ProQuest Distinguished Dissertation Award.
current job
organization founded
Mark J. Kiel
Steve Schwartz
CTO at CarcodeSMS
current job
organization founded
Steve Schwartz
Employee Profiles11
Dave Anstey
Vice president of sales and business development
